SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-04-079149
Filing Date
2004-05-05
Accepted
2004-05-05 14:46:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO SCHEDULE 13D dsc13da.htm SC 13D/A 26037
  Complete submission text file 0001193125-04-079149.txt   28097
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45277 | Film No.: 04781121
SIC: 2834 Pharmaceutical Preparations